Streetbeat News

Earnings

EVC

LYT

SCOR

WLY

In Thursday's intraday session, notable movements were observed in the Communication Services sector. Lytus Technologies Holdings led the gainers with a 582.2% increase, while Hanryu Holdings experienced the largest drop among the losers, declining by 15.6%. John Wiley & Sons reported Q3 earnings, contributing to an 11.11% rise in its stock price. Similarly, comScore and Entravision Communications reported their Q4 earnings, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:31 pm

EPOW

HDSN

RTO

UP

In Thursday's intraday session, several industrials stocks experienced significant movements. Notable gainers include Sunrise New Energy (EPOW), Velo3D (VLD), Rentokil Initial (RTO), JanOne (JAN), Byrna Technologies (BYRN), and Laser Photonics (LASE) with increases ranging from 16.29% to 22.0%. On the losing end, MingZhu Logistics Hldgs (YGMZ), SOS (SOS), Greenwave Tech Solns (GWAV), Hudson Technologies (HDSN), Pineapple Energy (PEGY), and Wheels Up Experience (UP) saw declines between 11.64% and 26.9%. Rentokil Initial and Wheels Up Experience released their Q4 earnings, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:31 pm

CMPO

CPSH

DAVE

MEI

In Thursday's intraday session, several Information Technology stocks experienced significant movements. Notably, CompoSecure, Dave, OneSpan, GSI Technology, GSE Systems, and SoundHound AI saw substantial gains, largely attributed to their recent Q4 earnings reports. Conversely, Methode Electronics, Infobird Co, MMTEC, Airship AI Holdings, CPS Technologies, and Cyngn faced declines, with earnings reports influencing several of these movements.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:31 pm

BRC

BRC shares experienced an uptick following the announcement of improved year-over-year Q4 GAAP EPS results.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:28 pm

GSK

GSK plc announced positive results from the DREAMM-8 phase III trial for Blenrep in combination therapy for multiple myeloma, showing significant improvement in progression-free survival compared to standard care. This comes after the withdrawal process of Blenrep's U.S. marketing authorization initiated in November 2022 due to a failed confirmatory trial. The company plans to present detailed findings at a future medical congress and share them with regulatory authorities.

Portfolio Pulse from Vandana Singh

March 07, 2024 | 5:18 pm

DSGX

Descartes Systems Group's shares increased following a report of better-than-expected Q4 revenues, leading to multiple analysts raising their price targets for the company.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:16 pm

CMPO

CompoSecure shares surged following the announcement of better-than-expected Q4 financial results and optimistic FY24 net sales guidance. Additionally, B. Riley Securities and Benchmark upgraded their price targets for the stock.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:16 pm

BJ

BJ's Wholesale Club shares are trading higher despite mixed Q4 results, indicating investor optimism or focus on positive aspects of the report.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:15 pm

SQNS

Sequans Communications (NYSE:SQNS) reported Q4 earnings with an EPS of $-0.23, missing estimates by -53.0% and a revenue decrease of $11.14 million from the previous year. Despite past earnings misses, the share price increased by 0.0% the day after last quarter's earnings were announced.

Portfolio Pulse from Benzinga Insights

March 07, 2024 | 5:15 pm

RSI

Rush Street Interactive, Inc. (NYSE:RSI) shares surged after reporting Q4 financial results surpassing estimates and providing 2024 revenue guidance above expectations. Q4 revenue was $193.85 million, a 17% increase year-over-year, beating estimates of $178.83 million. Adjusted EBITDA was $11.5 million, a significant improvement from a $17.3 million loss in the prior year. Monthly Active Users in the U.S. and Canada grew 7% to 160,000, while Latin America saw a 33% increase to 204,000. Adjusted EPS was $0.01, outperforming the expected loss of $0.03. The company ended the year with $168 million in unrestricted cash and cash equivalents. For 2024, Rush Street anticipates revenue between $770 million and $830 million, exceeding the $759.25 million estimate, with adjusted EBITDA projected at $35 million to $45 million. Shares rose 12% to $6.04.

Portfolio Pulse from Lekha Gupta

March 07, 2024 | 5:12 pm